JP2026063215A5 - - Google Patents
Info
- Publication number
- JP2026063215A5 JP2026063215A5 JP2026005807A JP2026005807A JP2026063215A5 JP 2026063215 A5 JP2026063215 A5 JP 2026063215A5 JP 2026005807 A JP2026005807 A JP 2026005807A JP 2026005807 A JP2026005807 A JP 2026005807A JP 2026063215 A5 JP2026063215 A5 JP 2026063215A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- composition
- nucleic acid
- arginine
- genetically modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062979805P | 2020-02-21 | 2020-02-21 | |
| US62/979,805 | 2020-02-21 | ||
| PCT/CN2021/077002 WO2021164753A1 (en) | 2020-02-21 | 2021-02-20 | Methods and compositions for modulating arginine levels in immune cells |
| JP2022550673A JP2023515806A (ja) | 2020-02-21 | 2021-02-20 | 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550673A Division JP2023515806A (ja) | 2020-02-21 | 2021-02-20 | 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026063215A JP2026063215A (ja) | 2026-04-10 |
| JP2026063215A5 true JP2026063215A5 (https=) | 2026-04-22 |
Family
ID=77390457
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550673A Pending JP2023515806A (ja) | 2020-02-21 | 2021-02-20 | 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物 |
| JP2026005807A Pending JP2026063215A (ja) | 2020-02-21 | 2026-01-16 | 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550673A Pending JP2023515806A (ja) | 2020-02-21 | 2021-02-20 | 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230265386A1 (https=) |
| EP (1) | EP4107254A4 (https=) |
| JP (2) | JP2023515806A (https=) |
| KR (1) | KR20220157396A (https=) |
| CN (1) | CN115427553A (https=) |
| AR (1) | AR121392A1 (https=) |
| AU (1) | AU2021223138A1 (https=) |
| BR (1) | BR112022016571A2 (https=) |
| CA (1) | CA3171901A1 (https=) |
| IL (1) | IL295606A (https=) |
| MX (1) | MX2022010280A (https=) |
| TW (1) | TW202144569A (https=) |
| WO (1) | WO2021164753A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202018554D0 (en) * | 2020-11-25 | 2021-01-06 | Cancer Research Tech Ltd | Nucleic acid constructs and cells |
| CN114788870B (zh) * | 2022-04-29 | 2023-06-06 | 浙江大学 | 靶向免疫细胞长效补充精氨酸并中和酸环境的组合物及应用 |
| WO2026063691A1 (ko) * | 2024-09-20 | 2026-03-26 | 삼성바이오에피스 주식회사 | 아르기니노숙시네이트 합성효소를 암호화하는 코돈-최적화된 폴리뉴클레오티드 및 이를 포함하는 rAAV 생산용 플라스미드 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013151665A2 (en) * | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins associated with human disease |
| JP7623784B2 (ja) * | 2016-10-13 | 2025-01-29 | ジュノー セラピューティクス インコーポレイテッド | トリプトファン代謝経路調節剤を含む免疫療法の方法および組成物 |
| GB201701332D0 (en) * | 2017-01-26 | 2017-03-15 | Tc Biopharm Ltd | Immune cells with modified metabolism and their use thereof |
| GB201721833D0 (en) * | 2017-12-22 | 2018-02-07 | Cancer Research Tech Ltd | Fusion proteins |
-
2021
- 2021-02-20 WO PCT/CN2021/077002 patent/WO2021164753A1/en not_active Ceased
- 2021-02-20 JP JP2022550673A patent/JP2023515806A/ja active Pending
- 2021-02-20 EP EP21757810.3A patent/EP4107254A4/en active Pending
- 2021-02-20 CN CN202180026648.4A patent/CN115427553A/zh active Pending
- 2021-02-20 CA CA3171901A patent/CA3171901A1/en active Pending
- 2021-02-20 US US17/800,958 patent/US20230265386A1/en active Pending
- 2021-02-20 MX MX2022010280A patent/MX2022010280A/es unknown
- 2021-02-20 AU AU2021223138A patent/AU2021223138A1/en active Pending
- 2021-02-20 KR KR1020227032553A patent/KR20220157396A/ko active Pending
- 2021-02-20 IL IL295606A patent/IL295606A/en unknown
- 2021-02-20 BR BR112022016571A patent/BR112022016571A2/pt unknown
- 2021-02-20 TW TW110105930A patent/TW202144569A/zh unknown
- 2021-02-22 AR ARP210100448A patent/AR121392A1/es unknown
-
2026
- 2026-01-16 JP JP2026005807A patent/JP2026063215A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7546925B2 (ja) | 核酸とｃａｒ修飾免疫細胞とを含む治療薬およびその使用 | |
| JP2026063215A5 (https=) | ||
| AU2017297610B2 (en) | Compositions and methods for alphavirus vaccination | |
| CA3244268A1 (en) | Enhanced adoptive cell therapy | |
| WO2019080537A1 (zh) | 包含溶瘤病毒和car-nk细胞的治疗剂及应用、药盒、治疗肿瘤和/或癌症的方法 | |
| WO2012172277A4 (en) | Simian adenovirus and hybrid adenoviral vectors | |
| CN115820696A (zh) | 治疗性多价HPV mRNA疫苗及其制备方法 | |
| CN101580817A (zh) | 含有细胞因子诱导杀伤细胞的细胞群的制造方法 | |
| CN113481167B (zh) | 一种免疫细胞外泌体及其应用 | |
| JP2023515806A5 (https=) | ||
| JP7836758B2 (ja) | がん処置のためのベクター | |
| CN113416260A (zh) | 靶向Claudin18.2的特异性嵌合抗原受体细胞及其制备方法和应用 | |
| CN115109774B (zh) | 一种新型同种异体car-t细胞的制备及应用 | |
| CN111499766B (zh) | 针对慢性淋巴细胞白血病的免疫效应细胞、其制备方法和应用 | |
| CN101063142B (zh) | 人乳头瘤病毒16型dna疫苗和基因佐剂及其应用 | |
| CN113832115A (zh) | 融合基因ril-7联合ccl19重组溶瘤牛痘病毒及其在制备抗肿瘤药物中的应用 | |
| CN115975056B (zh) | 利用天然蛋白tsh作为抗原结合位点构建靶向tshr的car-t细胞 | |
| CN102898508B (zh) | 封闭TGF-β受体或IL-10受体的多肽、其药物组合物及其用途 | |
| CN105585637A (zh) | 基于il-12稳定膜表达的肿瘤治疗剂及其制法和用途 | |
| US20240189374A1 (en) | Adenovirus for treatment of cancer | |
| TWI259206B (en) | A DNA vaccine containing a tumor associated gene and a cytokine gene and the method producing thereof | |
| CN1517437B (zh) | 特异性治疗肿瘤或胞内感染的疫苗及应用 | |
| WO2004072274A1 (en) | Virus-like particle vaccine containing dengue virus recombinant replicon as its carrier | |
| JP7572102B2 (ja) | 腫瘍溶解性遺伝子改変麻疹ウイルスの新規用途 | |
| HK40049493A (en) | Therapeutic agent comprising nucleic acid and car-modified immune cell and application thereof |